Structure analysis of a heteropolysaccharide from Taraxacum mongolicum Hand.-Matz. and anticomplementary activity of its sulfated derivatives

被引:57
作者
Chen, MiaoMiao
Wu, Jianjun
Shi, Songshan
Chen, Yonglin
Wang, Huijun
Fan, Hongwei
Wang, Shunchun [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Inst Chinese Mat Med, 1200 Cailun Rd, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Polysaccharide; Taraxacum mongolicum Hand.-Mazz; Sulfated derivative; Structure-activity relationship; Anticomplement; HEPARIN-BINDING SITE; ANTICOAGULANT ACTIVITY; COMPLEMENT-SYSTEM; POLYSACCHARIDES; CHROMATOGRAPHY; ALGAE; ARABINOGALACTAN; LOCALIZATION; IMMUNITY; INHIBIT;
D O I
10.1016/j.carbpol.2016.06.110
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A homogenous water-soluble polysaccharide, DPSW-A, with a deduced chemical structure was extracted from the herb Taraxacum mongolicum Hand.-Mazz. Moreover, 80.813-kDa DPSW-A is composed of three types of monosaccharide, namely rhamnose, arabinose, and galactose, at a molar ratio of 1.0:10.7:11.9. The main chain of DPSW-A contains Terminal-Galp, 1,3-Galp, 1,6-Galp, 1,3,6-Galp, and 1,2,4-Rhap; the branched chain contains Terminal-Araf, 1,5-Araf, and 1,3,5-Araf. The sulfated derivatives prepared from DPSW-A showed inhibitory effects on complement activation through the classical pathway (CH50: Sul-DPSW-A, 3.94 +/- 0.43 mu g/mL; heparin, 104.40 +/- 3.82 mu g/mL) and alternative pathway (AP(50): Sul-DPSW-A, 42.76 +/- 0.46 mu g/mL; heparin, 43.42 +/- 0.22 mu g/mL). Mechanism studies indicated that Sul-DPSW-A inhibited complement activation by blocking C1q, C1r, C1s, and C9, but not C2, C3, C4, and C5. In addition, Sul-DPSW-A displayed limited anticoagulant effects. These results suggest that Sul-DPSW-A prepared from DPSW-A is valuable for treating diseases caused by excessive complement system activation. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:241 / 252
页数:12
相关论文
共 36 条
  • [1] REQUIREMENT OF FREE CARBOXYL GROUPS FOR THE ANTICOAGULANT ACTIVITY OF HEPARIN
    AGARWAL, A
    DANISHEFSKY, I
    [J]. THROMBOSIS RESEARCH, 1986, 42 (05) : 673 - 680
  • [2] Relationships between chemical characteristics and anticomplementary activity of fucans
    Blondin, C
    Chaubet, F
    Nardella, A
    Sinquin, C
    Jozefonvicz, J
    [J]. BIOMATERIALS, 1996, 17 (06) : 597 - 603
  • [3] The complement system in regulation of adaptive immunity
    Carroll, MC
    [J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 981 - 986
  • [4] Conductivity detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans separated by high-performance size-exclusion chromatography
    Chaidedgumjorn, A
    Suzuki, A
    Toyoda, H
    Toida, T
    Imanari, T
    Linhardt, RJ
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2002, 959 (1-2) : 95 - 102
  • [5] An anti-complementary polysaccharide from the roots of Bupleurum chinense
    Di, Hongye
    Zhang, Yunyi
    Chen, Daofeng
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2013, 58 : 179 - 185
  • [6] Structure of a homofructosan from Saussurea costus and anti-complementary activity of its sulfated derivatives
    Fan, Hongwei
    Liu, Fei
    Bligh, S. W. Annie
    Shi, Songshan
    Wang, Shunchun
    [J]. CARBOHYDRATE POLYMERS, 2014, 105 : 152 - 160
  • [7] Structure and anticoagulant activity of sulfated galactans -: Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action wtth that of sulfated galactans from invertebrates
    Farias, WRL
    Valente, AP
    Pereira, MS
    Mourao, PAS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) : 29299 - 29307
  • [8] Relationship between sulfate groups and biological activities of fucans
    Haroun-Bouhedja, F
    Ellouali, M
    Sinquin, C
    Boisson-Vidal, C
    [J]. THROMBOSIS RESEARCH, 2000, 100 (05) : 453 - 459
  • [9] STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE FORMATION OF THE HUMAN AMPLIFICATION C3-CONVERTASE
    KAZATCHKINE, MD
    FEARON, DT
    METCALFE, DD
    ROSENBERG, RD
    AUSTEN, KF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (01) : 223 - 228
  • [10] Controlling the complement system in inflammation
    Kirschfink, M
    [J]. IMMUNOPHARMACOLOGY, 1997, 38 (1-2): : 51 - 62